The availability of a rule-in-rule-out test for Alzheimer’s disease in primary care settings is likely to drive efficiencies throughout the care continuum.

Adaptyx Biosciences announced today it has raised $14 million in seed financing, bringing total funding to $23 million since inception. The round was led by Interlagos, with significant participation ...

Low cholesterol can reduce the risk of dementia, a new University of Bristol-led study with more than a million participants ...

“Our discovery offers the potential for a simple, accurate blood test to help confirm a diagnosis, which could lead to ...

Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...

According to the release, this is the first study globally to demonstrate that Sinapic acid, when administered orally, can accelerate diabetic wound healing in preclinical models. The research ...

Adaptyx Biosciences announced today that it raised $14 million in seed funding to support its multi-analyte molecular ...

Learn about pet bloodwork, the tests involved, and how to interpret results to ensure your furry friend's health. Read the ...

Neurofilament light chains in the serum and cerebrospinal fluid show strong potential for monitoring neurodegenerative and ...

Bengaluru: Students getting admitted to postgraduate medical or dental degree courses in Karnataka will have to furnish a ...